Armistice Capital’s Addex Therapeutics ADXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-43,000
| Closed | -$260K | – | 335 |
|
|
2023
Q4 | $260K | Buy |
43,000
+16,150
| +60% | +$97.7K | ﹤0.01% | 219 |
|
|
2023
Q3 | $206K | Buy |
26,850
+13,650
| +103% | +$105K | ﹤0.01% | 196 |
|
|
2023
Q2 | $138K | Buy |
+13,200
| New | +$138K | ﹤0.01% | 182 |
|
|
2022
Q4 | – | Sell |
-16,000
| Closed | -$256K | – | 192 |
|
|
2022
Q3 | $256K | Buy |
16,000
+3,349
| +26% | +$53.6K | ﹤0.01% | 158 |
|
|
2022
Q2 | $291 | Sell |
12,651
-15,753
| -55% | -$362 | 0.01% | 149 |
|
|
2022
Q1 | $2.89M | Sell |
28,404
-2,358
| -8% | -$240K | 0.06% | 88 |
|
|
2021
Q4 | $3.87M | Buy |
+30,762
| New | +$3.87M | 0.06% | 114 |
|